AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "cg1127-neonatal-abstinence-scoring-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 6543
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Neonatal Abstinence Syndrome Assessment and Management",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "The text does not explicitly mention the publishing organization or institution. However, based on the content and style, it is likely from a **NHS Trust** or similar healthcare institution, but no specific acronym like NICE, WHO, or RCOG is stated. Since the guideline references \"Trust and National recommendations,\" the closest inferred organization is: **NHS**",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "There is no publication year mentioned in the provided text. If you have another guideline text with a visible publication year, please share it, and I'll extract the year for you",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Recommendations**: - **Assessment**: Monitor for withdrawal symptoms using scoring tools. - **Antenatal Care**: Provide education, neonatal unit visits if needed, Hepatitis B vaccination, and social services referral. - **Perinatal Care**: Avoid Pethidine/Diamorphine in opiate-dependent mothers; do not give Naloxone. - **Postnatal Care**: Keep mother and baby together; observe for withdrawal; initiate scoring and pharmacological treatment if needed. - **Pharmacological Treatment**: - **Opiate withdrawal**: Start morphine (125 mcg/kg/day, 4x daily), wean based on NAS scores. - **Non-opiate withdrawal**: Phenobarbitone for alcohol, chlorpromazine for benzodiazepines. - **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine dose changes for 36 hours. - **Follow-up**: Ensure discharge planning, social support, and medication weaning schedule. **Additional Measures**: - Hepatitis B vaccine/immunoglobulin for high-risk infants. - Avoid breastfeeding if contraindicated by maternal medication. - Provide parental education and support. **Audit**: Monitor antenatal tasks, NAS scoring, and discharge planning compliance",
      "action": "added"
    }
  ]
}